Kaylyn E. Williamson

An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia

Birgit Knoechel, Justine E. Roderick, Kaylyn E. Williamson et al. · Nature Genetics · 2014 · 382 citations · Full text

Medicine, Molecular Biology, Oncology +16

Locus-specific editing of histone modifications at endogenous enhancers

Eric M. Mendenhall, Kaylyn E. Williamson, Deepak Reyon et al. · Nature Biotechnology · 2013 · 367 citations · Full text

Life Sciences, Genetics, Molecular Biology +16

An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells

Maia Vinogradova, Victor Gehling, Amy Gustafson et al. · Nature Chemical Biology · 2016 · 357 citations · Full text

Medicine, Oncology, Pharmacology +14

An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma

Yotam Drier, Matthew J. Cotton, Kaylyn E. Williamson et al. · Nature Genetics · 2016 · 301 citations · Full text

Veterinary Medicine, Molecular Biology, Oncology +10

EZH2 Inhibitor Efficacy in Non-Hodgkin’s Lymphoma Does Not Require Suppression of H3K27 Monomethylation

William D. Bradley, Shilpi Arora, Jennifer Busby et al. · Chemistry & Biology · 2014 · 148 citations

Medicine, Oncology, Pharmacology +11